Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats

Nutrition Research

Volumn 28, Issue 6, 2008, Pages 391-398

  Silva, Maísa ^a   Silva, Marcelo E ^a   de Paula, Heberth ^a   Carneiro, Cláudia Martins ^a   Pedrosa, Maria Lucia ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Hepatic steatosis; Hyperlipemic diet; Iron overload; Rat; Serum glucose and lipids

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IRON DEXTRAN; LIPID; MALONALDEHYDE; SODIUM CHLORIDE; SOYBEAN OIL; THIOL DERIVATIVE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY LIVER; FISCHER 344 RAT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; IRON OVERLOAD; LIPID DIET; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CHOLESTEROL; DIETARY FATS; FATTY LIVER; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HYPERLIPIDEMIAS; IRON; IRON OVERLOAD; LIPID METABOLISM; LIPID PEROXIDATION; LIPIDS; LIVER; MALE; RATS; RATS, INBRED F344; TRANSFERRIN; TRIGLYCERIDES;

GLYCINE MAX; RATTUS;

EID: 44149123348     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.02.009     Document Type: Article

References (40)

1. Tuomainen T.P., Punnonen K., Nyyssonen K., and Salonen J.T. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97 (1991) 1461-1466
2. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 53-S3 (2003) 26-36
3. Bunker V.W. Free radicals, antioxidants and ageing. Med Lab Sci 49 (1992) 299-312
4. Halliwell B., and Gutteridge J.M. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1 (1990) 1-8
5. Sheth S., and Brittenham G.M. Genetic disorders affecting proteins of iron metabolism: clinical implications. Annu Rev Med 51 (2000) 443-464
6. Olsson K.S., Heedman P.A., and Staugard F. Preclinical hemochromatosis in a population on a high-iron-fortified diet. J Amer Med Assoc 239 (1978) 1999-2000
7. Olsson K.S., Marsell R., Ritter B., Olander B., Akerblom A., Ostergard H., et al. Iron deficiency and iron overload in Swedish male adolescents. J Intern Med 237 (1995) 187-194
8. Fleming D.J., Tucker K.L., Jacques P.F., Dallal G.E., Wilson P.W., and Wood R.J. Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am J Clin Nutr 6 (2002) 1375-1384
9. Britton R.S., Bacon B.R., and Recknagel R.O. Lipid peroxidation and associated hepatic organelle dysfunction in iron overload. Chem Phys Lipids 45 (1987) 207-239
10. Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., and Hu F.B. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. J Amer Med Assoc 291 (2004) 711-717
11. Tuomainen T.P., Nyyssonen K., Salonen R., Tervahauta A., Korpela H., Lakka T., et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 20 (1997) 426-428
12. Sullivan J.L. Iron therapy and cardiovascular disease. Kidney Int 69 (1999) S135-S137
13. Williams M.J., Poulton R., and Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 165 (2002) 179-184
14. Piperno A., Trombini P., Gelosa M., Mauri V., Pecci V., Vergani A., et al. Increased serum ferritin is common in men with essential hypertension. J Hypertens 20 (2002) 1513-1518
15. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46 (2007) 1392-1403
16. Brunet S., Thibault L., Delvin E., Yotov W., Bendayan M., and Levy E. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 29 (1999) 1809-1817
17. Knutson M.D., Walter P.B., Ames B.N., and Viteri F.E. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr 130 (2000) 621-628
18. Turbino-Ribeiro S.M.L., Silva M.E., Chianca Jr. D.A., Paula H., Cardoso L.M., Colombari E., et al. Iron overload in hyperlipemic rats affects iron homeostasis and serum lipids but not blood pressure. J Nutr 133 (2003) 15-20
19. Brown K.E., Dennery P.A., Ridnour L.A., Fimmel C.J., Kladney R.D., Brunt E.M., et al. Effect of iron overload and dietary fat on indices of oxidative stress and hepatic fibrogenesis in rats. Liver Int 23 (2003) 232-242
20. Colégio Brasileiro de Experimentação Animal. Princípios Éticos na Experimentação Animal do Colégio Brasileiro de Experimentação Animal (1991), COBEA, São Paulo
21. Association of Official Analytical Chemists. Official methods of analysis (1980), AOAC, Washington
22. Sedlak J., and Lindsay R.H. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25 (1968) 192-205
23. Beltowski J., Wojcicka G., and Jamroz A. Differential effect of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors on plasma paraoxonase 1 activity in the rat. Pol J Pharmacol 54 (2002) 661-671
24. Park C.H., Bacon B.R., Brittenham G.M., and Tavill A.S. Pathology of dietary carbonyl iron overload in rats. Lab Invest 57 (1987) 555-563
25. Tavill A.S., Sharma B.K., and Bacon B.R. Iron and the liver: genetic hemochromatosis and other hepatic iron overload disorders. Prog Liver Dis 9 (1990) 281-305
26. Dabbagh A.J., Mannion T., Lynch S.M., and Frei B. The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem J 300 (1994) 799-803
27. Du C., Fujii Y., Ito M., Harada M., Moriyama E., Shimada R., et al. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. J Nutr Biochem 15 (2004) 273-280
28. Moghadasian M.H. Experimental atherosclerosis: a historical overview. Life Sci 70 (2002) 855-865
29. Araujo J.A., Romano E.L., Brito B.E., Parthé V., Romano M., Bracho M., et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 15 (1995) 1172-1180
30. Rodriguez A., Hilvo M., Kytomaki L., Fleming R.E., Britton R.S., Bacon B.R., et al. Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse. BMC Genomics 8 (2007) 379 10.1186/1471-2164-8-379
31. Mendler M.H., Turlin B., Moirand R., Jouanolle A.M., Sapey T., Guyader D., et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 117 (1999) 1155-1163
32. Ramey G., Faye A., Durel B., Viollet B., and Vaulont S. Iron overload in Hepc1(-/-) mice is not impairing glucose homeostasis. FEBS Lett 581 (2007) 1053-1057
33. Masini A., Ceccarelli D., Giovannini F., Montosi G., Garuti C., and Pietrangelo A. Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils. The effect of silybin. J Bioenerg Biomembr 32 (2000) 175-182
34. Ceccarelli D., Gallesi D., Giovannini F., Ferrali M., and Masini A. Relationship between free iron level and rat liver mitochondrial dysfunction in experimental dietary iron overload. Biochem Biophys Res Commun 209 (1995) 1-6
35. Lykkesfeldt J., Morgan E., Christen S., Skovgaard L.T., and Moos T. Oxidative stress and damage in liver, but not in brain, of Fischer 344 rats subjected to dietary iron supplementation with lipid-soluble [(3,5,5-trimethylhexanoyl)ferrocene]. J Biochem Mol Toxicol 21 (2007) 145-155
36. Ayub A., Mackness M.I., Arrol S., Mackness B., Patel J., and Durrington P.N. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 19 (1999) 330-335
37. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101 (1998) 1581-1590
38. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., Ishola M., et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86 (1991) 193-199
39. Nguyen S.D., and Sok D.E. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radical Res 37 (2003) 1319-1330
40. Trudel K., Sinnett D., James R.W., Delvin E., Amre D., Seidman E., et al. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats. J Cell Biochem 96 (2005) 404-411